Placental malaria among HIV-infected and uninfected women receiving anti-folates in a high transmission area of Uganda

Simple item page
dc.contributor.authorNewman, Patrick M.
dc.contributor.authorWanzira, Humphrey
dc.contributor.authorTumwine, Gabriel
dc.contributor.authorArinaitwe, Emmanuel
dc.contributor.authorWaldman, Sarah
dc.contributor.authorClark, Tamara D.
dc.contributor.authorCohan, Deborah
dc.date.accessioned2025-02-24T08:52:48Z
dc.date.available2025-02-24T08:52:48Z
dc.date.issued2009-11-14
dc.description.abstractHIV infection increases the risk of placental malaria, which is associated with poor maternal and infant outcomes. Recommendations in Uganda are for HIV-infected pregnant women to receive daily trimethoprim-sulphamethoxazole (TS) and HIV-uninfected women to receive intermittent sulphadoxine-pyrimethamine (SP). TS decreases the risk of malaria in HIV-infected adults and children but has not been evaluated among pregnant women.
dc.identifier.citationNewman, P. M., Wanzira, H., Tumwine, G., Arinaitwe, E., Waldman, S., Achan, J., ... & Cohan, D. (2009). Placental malaria among HIV-infected and uninfected women receiving anti-folates in a high transmission area of Uganda. Malaria Journal, 8, 1-9.https://doi.org/10.1186/1475-2875-8-254
dc.identifier.otherhttps://doi.org/10.1186/1475-2875-8-254
dc.identifier.urihttps://nru.uncst.go.ug/handle/123456789/9989
dc.language.isoen
dc.publisherMalaria Journal
dc.titlePlacental malaria among HIV-infected and uninfected women receiving anti-folates in a high transmission area of Uganda
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
1475-2875-8-254.pdf
Size:
441.74 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Medical and Health Sciences